MCHR1
Melanin-concentrating hormone receptor 1
Also known as: GPR24, MCH1R, MCHR1_HUMAN, SLC1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99705
- Gene
- MCHR1
- Ensembl
- ENSG00000128285
- Chromosome
- 22
- Canonical length
- 353 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene, a member of the G protein-coupled receptor family 1, is an integral plasma membrane protein which binds melanin-concentrating hormone. The encoded protein can inhibit cAMP accumulation and stimulate intracellular calcium flux, and is probably involved in the neuronal regulation of food consumption. Although structurally similar to somatostatin receptors, this protein does not seem to bind somatostatin. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
353 residues, UniProt reviewed canonical sequence.
>Q99705|MCHR1
1 MDLEASLLPT GPNASNTSDG PDNLTSAGSP PRTGSISYIN IIMPSVFGTI CLLGIIGNST
61 VIFAVVKKSK LHWCNNVPDI FIINLSVVDL LFLLGMPFMI HQLMGNGVWH FGETMCTLIT
121 AMDANSQFTS TYILTAMAID RYLATVHPIS STKFRKPSVA TLVICLLWAL SFISITPVWL
181 YARLIPFPGG AVGCGIRLPN PDTDLYWFTL YQFFLAFALP FVVITAAYVR ILQRMTSSVA
241 PASQRSIRLR TKRVTRTAIA ICLVFFVCWA PYYVLQLTQL SISRPTLTFV YLYNAAISLG
301 YANSCLNPFV YIVLCETFRK RLVLSVKPAA QGQLRAVSNA QTADEERTES KGTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MCHR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 9.9 nTPM
Expression across tissuesHPA
Tissue
- ovary: 9.9 nTPM
- cerebral cortex: 9.3 nTPM
- hypothalamus: 6.5 nTPM
- endometrium: 5.5 nTPM
- hippocampal formation: 3.4 nTPM
- heart muscle: 3.2 nTPM
Single-cell type
- pancreatic islet cells: 8 nCPM
- ovarian stromal cells: 6.7 nCPM
- melanocytes: 6.2 nCPM
- other brain neurons: 4.4 nCPM
- gonadotrophs: 3 nCPM
- brain inhibitory neurons: 2.8 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 17 nTPM
- hypothalamus: 15 nTPM
- pons: 11 nTPM
- basal ganglia: 10 nTPM
- hippocampal formation: 8.2 nTPM
- thalamus: 7.3 nTPM
ReferencesPubMed · IEDB
Publications for MCHR1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Autoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptor.
2003 · J Invest Dermatol · RCR 0.5 · 18 citations - Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies.
2009 · Exp Dermatol · RCR 0.4 · 13 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.75
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- cell surface receptor signaling pathway
- feeding behavior
- G protein-coupled receptor signaling pathway
- generation of precursor metabolites and energy
- neuropeptide signaling pathway
- positive regulation of calcium ion transport
- positive regulation of cytosolic calcium ion concentration
Molecular functions
- G protein-coupled receptor activity
- hormone binding
- neuropeptide binding
- neuropeptide receptor activity
- signaling receptor binding
- melanin-concentrating hormone receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- G protein-coupled receptor, rhodopsin-like
- Melanin-concentrating hormone receptor
- GPCR, rhodopsin-like, 7TM
- 7 transmembrane receptor (rhodopsin family)
- Melanin-concentrating hormone receptor 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MCHR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MCHR1 as an antibody target. Whether an autoantibody or antibody against MCHR1 could matter depends on whether native MCHR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MCHR1 is annotated at the cell surface, where native MCHR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MCHR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...